The pharmaceutical world is seeing a significant shift in blood sugar management with the introduction of GLP-1 patches. These patches offer a seemingly more user-friendly alternative to shots of GLP-1 receptor agonists, minimizing the need for daily needle pokes. The innovation delivers the comp